Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study
- 13 January 2004
- journal article
- clinical trial
- Published by Springer Nature in International Journal of Obesity
- Vol. 28 (3) , 378-383
- https://doi.org/10.1038/sj.ijo.0802574
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Evaluation of a foot-to-foot bioelectrical impedance analyser in highly active, moderately active and less active young menBritish Journal of Nutrition, 2002
- Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trialInternational Journal of Obesity, 2001
- Effect of sibutramine on weight maintenance after weight loss: a randomised trialThe Lancet, 2000
- Efficacy and Safety of Sibutramine in Obese White and African American Patients With HypertensionArchives of internal medicine (1960), 2000
- Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Sibutramine in Obese Hypertensive PatientsCardiology, 2000
- Overweight and obesity in the United States: prevalence and trends, 1960–1994International Journal of Obesity, 1997
- A Double‐Blind Randomized Placebo‐Controlled Trial of SibutramineObesity Research, 1996
- Obesity and Insurance RiskPharmacoEconomics, 1994
- Actual Causes of Death in the United StatesJAMA, 1993
- Weight Loss Intervention in Phase 1 of the Trials of Hypertension PreventionArchives of internal medicine (1960), 1993